<!–

–>

March 20, 2024

Once the envy of the world, American medical care continues to be infected with Leftist woke ideology with abysmal and terrifying outcomes.

‘); googletag.cmd.push(function () { googletag.display(‘div-gpt-ad-1609268089992-0’); }); document.write(”); googletag.cmd.push(function() { googletag.pubads().addEventListener(‘slotRenderEnded’, function(event) { if (event.slot.getSlotElementId() == “div-hre-Americanthinker—New-3028”) { googletag.display(“div-hre-Americanthinker—New-3028”); } }); }); }

Under the term “health equity” the only parameter that matters appears to be a person’s melanin level, not his need for timely medical treatment.

Consequently:

More than 10 million nonblack Americans with chronic kidney disease may have seen their treatments or transplants delayed because of policy changes enacted after 2020.  Some of those patients now face greater risk of death because national transplant organizations have embraced racial activism.

‘); googletag.cmd.push(function () { googletag.display(‘div-gpt-ad-1609270365559-0’); }); document.write(”); googletag.cmd.push(function() { googletag.pubads().addEventListener(‘slotRenderEnded’, function(event) { if (event.slot.getSlotElementId() == “div-hre-Americanthinker—New-3035”) { googletag.display(“div-hre-Americanthinker—New-3035”); } }); }); }

Patients of all races deserve a formula that accurately estimates their individual kidney function, not one that favors one racial group at the expense of others. 

Then there is the Advil Pain Equity Project to end “systemic pain racism.”  It should be noted that Advil is owned by Pfizer. In fact, as explained in FortuneWell,

According to a study, three out of four Black people believe there is bias in how their pain is diagnosed. Now Advil, a popular pain relief brand, is aiming to address inequity in pain diagnosis and treatment with the Advil Pain Equity Project.

As part of the multiyear project, Advil is awarding grants to the Morehouse School of Medicine and BLKHLTH, an Atlanta-based nonprofit, to support the development of patient resources and a course for medical school students to address pain equity both in and outside of medical facilities.

Dare one ponder the possibility that this is merely “a plan to sell $50 million more in pills to Black people – disguised as a fight to end ‘pain racism?’”

On the other hand, keynote speaker at the 2023 Social Justice Awards sponsored by Institutional Diversity & Equity (ID&E), “author, physician, and thought leader Dr. Uche Blackstock, founder of Advancing Health Equity, is committed to dismantling racism in health care and closing the gap in racial health inequities.” 

Consequently, in 2024, is the American patient caught between the greed of pharmaceutical companies and the vise of leftwing social justice activists?  And this does not even begin to analyze the spiraling health care costs that have long confounded Americans.

Moreover, faith in American medicine has certainly been tarnished by the treatment afforded those health care workers who dared to question the federal government’s edicts concerning the mRNA Covid-19 “vaccines.”